Donald Pearl
Direktor/Vorstandsmitglied bei Child Neurology Foundation
Profil
Donald Pearl is currently the Director at Child Neurology Foundation.
Prior to this, he was the Chief Executive Officer at Aruene Corp.
in 2020 and the Vice President-Neurology at Ipsen Biopharmaceuticals, Inc. from 2014 to 2019.
Aktive Positionen von Donald Pearl
Unternehmen | Position | Beginn |
---|---|---|
Child Neurology Foundation | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Donald Pearl
Unternehmen | Position | Ende |
---|---|---|
Aruene Corp.
Aruene Corp. Medical SpecialtiesHealth Technology Aruene Corp. develops portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for treatment of migraine. It offers SpringTMS, a transcranial magnetic stimulation device for the acute treatment of pain associated with migraine headache with aura. The company was founded by Robert E. Fischell and David R. Fischell in 2002 and is headquartered in Baltimore, MD. | Vorstandsvorsitzender | 01.08.2020 |
Ipsen Biopharmaceuticals, Inc. | Corporate Officer/Principal | 01.04.2019 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Aruene Corp.
Aruene Corp. Medical SpecialtiesHealth Technology Aruene Corp. develops portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for treatment of migraine. It offers SpringTMS, a transcranial magnetic stimulation device for the acute treatment of pain associated with migraine headache with aura. The company was founded by Robert E. Fischell and David R. Fischell in 2002 and is headquartered in Baltimore, MD. | Health Technology |
Child Neurology Foundation | |
Ipsen Biopharmaceuticals, Inc. |